Copay Assistance
Eligible patients pay as little as
$10 per month for
JYNARQUE® (tolvaptan)*
of patients with commercial insurance have coverage†
of all patients pay $10 or less per month for JYNARQUE, regardless of coverage type‡
Since a REMS-certified Specialty Pharmacy will deliver JYNARQUE directly to your door, you do not need a copay card. Make sure to tell your Specialty Pharmacy that you are interested in having your copay support applied directly to lowering your out-of-pocket costs.
Receive helpful texts and
emails with information to support conversations with your nephrologist
and healthcare team.
Speak one-on-one with
a Peer Mentor living with
rapidly progressing ADPKD
and taking JYNARQUE.
Sign up for an ADPKD
Peer Conversations webinar
to talk with people living
with ADPKD.
ADPKD=autosomal dominant polycystic kidney disease; REMS=Risk Evaluation and Mitigation Strategy.
*Assumes one 28-day supply prescription per month. If more than one prescription is filled in a calendar month, you may pay more than $10 in that month. Offer is not transferable. Patients are not eligible if they are under 18 years of age or are covered in whole or in part by any state program or federal healthcare program, including, but not limited to, Medicare or Medicaid (including Medicaid managed care), Medigap, VA, DOD, or TRICARE. Patients must have a prescription consistent with FDA-approved product labeling for JYNARQUE. Only valid in US and Puerto Rico. Offer void where prohibited by law, taxed, or restricted. Other restrictions may apply. This program is not health insurance. Otsuka America Pharmaceutical, Inc. has the right to rescind, revoke, or amend this program at any time without notice. Your participation in this program confirms that this offer is consistent with your insurance coverage and that you will report the value received if required by your insurance provider. When you use this program, you are certifying that you understand and comply with the program rules, terms, and conditions. The information provided in this communication is provided for informational purposes and does not guarantee coverage or payment (partial or full). Actual benefits are determined by each plan’s administrator in accordance with its respective policy and procedures. Providers should consult with their payers for all relevant coverage, coding, and reimbursement requirements. It is the sole responsibility of the provider to ensure the accuracy of all claims used in seeking reimbursement. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced. This communication is solely the responsibility of Otsuka America Pharmaceutical, Inc. This resource is not intended as legal advice or a substitute for a provider’s independent professional judgment.
†Managed Markets Insight & Technology, LLC database as of July 2023.
‡Managed Markets Insight & Technology, LLC: Analytics website as of June 21, 2022. Commercial lives exclude Health Insurance Exchanges Program (HIX) data.